(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TETRAVARINEX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

TETRAVARINEX

ST13

US500000079036245

Class

5

Filing

79036245

Registration

3423146

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

12/13/2025

Trademark type

Word

Nice classes

5

Filing date

11/20/2006

Registration date

05/06/2008

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/12/2014

Last transaction

12/13/2025

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

98

Owner location

GB

Examiner

CORWIN,CHARLOTTE K

Law office

M80

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Jazz Pharmaceuticals Research UK Limited
GW Research Limited
GW Pharma Limited

Representatives

Michelle L. Visser c/o Dominic Schiller

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of obesity associated with type II diabetesnon-insulin dependant diabetes; pharmaceutical preparations for the treatment of bulimia; pharmaceutical preparations for the treatment of schizophrenia; pharmaceutical preparations for the treatment of epilepsy; pharmaceutical preparations for the treatment of cognitive disorderssuch as Alzheimer's; pharmaceutical preparations for the treatment of bone disorders; pharmaceutical preparations for the treatment of drugalcohol or nicotine abuse; pharmaceutical preparations for the treatment of inflammatory disorders

Publications

History of USPTO decisions and trademark events.

37 publications found

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

12/11/2025

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

01/30/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/24/2021

CHLD

CHANGE OF OWNER RECEIVED FROM IB

09/13/2018

NREP

NEW REPRESENTATIVE AT IB RECEIVED

12/21/2017

RNWL

INTERNATIONAL REGISTRATION RENEWED

12/15/2016

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

09/24/2015

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

09/03/2015

INPC

INVALIDATION PROCESSED

09/03/2015

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

08/12/2015

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

06/19/2015

C71T

CANCELLED SECTION 71

12/12/2014

NREP

NEW REPRESENTATIVE AT IB RECEIVED

08/07/2014

GPNX

NOTIFICATION PROCESSED BY IB

06/13/2014

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

12/22/2012

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/01/2011

FICS

FINAL DISPOSITION NOTICE SENT TO IB

08/26/2008

FIMP

FINAL DISPOSITION PROCESSED

08/26/2008

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/06/2008

R.PR

REGISTERED-PRINCIPAL REGISTER

05/06/2008

PUBO

PUBLISHED FOR OPPOSITION

02/19/2008

NPUB

NOTICE OF PUBLICATION

01/30/2008

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

01/16/2008

ALIE

ASSIGNED TO LIE

01/16/2008

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/04/2007

DOCK

ASSIGNED TO EXAMINER

11/28/2007

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/09/2007

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/08/2007

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/08/2007

RFNT

REFUSAL PROCESSED BY IB

05/25/2007

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

05/10/2007

RFRR

REFUSAL PROCESSED BY MPU

05/10/2007

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

05/09/2007

CNRT

NON-FINAL ACTION WRITTEN

05/08/2007

DOCK

ASSIGNED TO EXAMINER

04/27/2007

NWAP

NEW APPLICATION ENTERED

04/27/2007

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

04/26/2007

Continuous trademark protection

Get notified about every new filing that threatens TETRAVARINEX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.